01Clinical context
What is the finding?
Comedonal, inflammatory and nodulocystic acne must be separated from folliculitis, perioral dermatitis and rosacea; severity, distribution, scarring risk, medicines and hormonal or systemic context matter.
Medical Skin Care for Acne · Medical Skin Care · Istanbul
Medical Skin Care for Acne · Medical Skin Care · Istanbul
Medical Skin Care for Acne
Cleansing and cosmetic care do not replace medical acne treatment. A named care method, ingredient or infusion is not a diagnosis and does not establish personal suitability.
Online information cannot diagnose, select products or procedures, or promise an outcome. Final decisions require an in-person medical assessment.
Clinical Orientation
Finding · identity · evidence · safety
Four questions precede a personal plan.
The sequence prevents a category name from becoming an automatic treatment recommendation.
02Identity
What exactly is proposed?
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
03Evidence
What does the evidence support?
Skin-care evidence must be read alongside acne severity and any disease-directed treatment.
04Safety
When should it stop?
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
Meaning and Boundary
Care is not a diagnosis
The category name does not determine the clinical decision.
Cleansing and cosmetic care do not replace medical acne treatment.
What assessment may do
- Clarify a limited clinical aim
- Identify the exact method or product
- Compare risks and alternatives
- Set follow-up and stopping criteria
What must not be assumed
- Guarantee suitability or benefit
- Replace diagnosis or disease-directed treatment
- Create a public personal protocol
- Promise permanence, prevention or a general wellness effect
A cosmetic extraction or cleansing session cannot diagnose or treat every form of acne.
Medical Suitability
Diagnosis and activity before care
Five checks come before selection.
History, examination, current treatment, contraindications and a proportionate alternative are reviewed together.
- 01
Clarify the problem
Comedonal, inflammatory and nodulocystic acne must be separated from folliculitis, perioral dermatitis and rosacea; severity, distribution, scarring risk, medicines and hormonal or systemic context matter.
- 02
Review current treatment
Medicines, allergies, previous procedures or infusions and relevant reactions are considered.
- 03
Identify the exact option
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
- 04
Compare alternatives
Medical acne assessment, prescribed treatment where appropriate, simple non-irritating care, observation or referral
- 05
Plan follow-up
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
Care Path
Before · during · after
Safety depends on a complete, documented chain.
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
01Before
Confirm finding and skin state
Comedonal, inflammatory and nodulocystic acne must be separated from folliculitis, perioral dermatitis and rosacea; severity, distribution, scarring risk, medicines and hormonal or systemic context matter.
- Review history and examination
- Check contraindications
- Keep alternatives open
02During
Control exposure and response
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
- Maintain traceability
- Monitor tolerance
- Stop when safety changes
03After
Separate expected response from harm
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
- Record observations
- Explain warning signs
- Provide a review route
No personal acid concentration, contact time, prescription medicine or home-treatment recipe is published.
Evidence and Limits
Method-, product- and indication-specific
Biology or popularity is not proof of clinical benefit.
Skin-care evidence must be read alongside acne severity and any disease-directed treatment.
Keep the indication exact
Evidence in one diagnosis or deficiency does not establish a general effect.
Keep the intervention exact
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
Keep endpoints separate
Symptoms, photographs, laboratory values and patient-reported outcomes are not interchangeable.
Retain uncertainty
A cosmetic extraction or cleansing session cannot diagnose or treat every form of acne.
Manufacturer information may identify a product and instructions, but it is not treated as independent evidence of a general class effect.
Individual Plan
Reason · option · review · exit
Personalisation means tighter decisions, not unlimited combinations.
A plan remains limited to a defined question and can conclude that no procedure or infusion is appropriate.
Name the reason
Comedonal, inflammatory and nodulocystic acne must be separated from folliculitis, perioral dermatitis and rosacea; severity, distribution, scarring risk, medicines and hormonal or systemic context matter.
Name the option
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
Name the endpoint
Agree what would count as a meaningful and measurable change.
Name the exit
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
Course and Follow-Up
Expected response · complication · reassessment
Repetition is never automatic.
Tolerance and the agreed clinical endpoint are reviewed separately before any further intervention.
- 01Before
Baseline
Record the starting clinical context and intended endpoint.
- 02Same day
Immediate review
Observe tolerance and unexpected reactions.
- 03Later
Clinical review
Compare the relevant finding without automatic attribution.
- 04Decision
Continue, change or stop
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
Risks and Alternatives
Common, serious and delayed harm
Risk remains visible even when a treatment is described as supportive.
Irritation, allergic reaction, barrier damage, delayed effective treatment and worsening inflammation or scarring may occur.
01Safety
Recognised harms
Irritation, allergic reaction, barrier damage, delayed effective treatment and worsening inflammation or scarring may occur.
02Options
Alternatives
Medical acne assessment, prescribed treatment where appropriate, simple non-irritating care, observation or referral
03Action
Escalation
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
04Decision
Withhold or stop
Treatment is withheld or stopped when the indication, consent, safety controls or follow-up cannot support a proportionate plan.
Treatment is withheld when diagnosis or rationale, product identity, consent, safety controls or follow-up is inadequate. Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
Istanbul and Follow-Up
Assessment and review must travel together
International care needs a workable safety route.
Travel does not shorten observation or remove the need for local medical access.
01Before travel
Organise the question
History and existing records prepare discussion without confirming treatment.
02In Istanbul
Assess in person
Comedonal, inflammatory and nodulocystic acne must be separated from folliculitis, perioral dermatitis and rosacea; severity, distribution, scarring risk, medicines and hormonal or systemic context matter.
03Treatment day
Keep exact records
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
04After return
Plan escalation
Painful nodules, rapidly increasing inflammation, infection, widespread scarring or systemic symptoms require medical assessment.
The Doctor Aslan Approach
Clinical question before treatment label
Selection follows diagnosis, identity, evidence and safety.
Doctor Aslan keeps the clinical question, exact intervention, realistic limits, alternatives and follow-up in the same decision.
Assess first
Comedonal, inflammatory and nodulocystic acne must be separated from folliculitis, perioral dermatitis and rosacea; severity, distribution, scarring risk, medicines and hormonal or systemic context matter.
Verify identity
A care plan may support cleansing, moisturisation and photoprotection, but does not supply a public antibiotic, retinoid, hormonal or isotretinoin prescription.
Limit the claim
A cosmetic extraction or cleansing session cannot diagnose or treat every form of acne.
Accept no treatment
Observation or another established pathway may be the safer choice.
Medical responsibility: Dr İsmail AslanMedical review: 24 August 2026General patient information about Medical Skin Care for Acne; no personal prescription or outcome guarantee
Frequently Asked Questions
Short and clear
Questions commonly asked before a decision.
These answers provide general orientation and do not replace personal diagnosis or treatment planning.
01What is Medical Skin Care for Acne?+
Medical Skin Care for Acne is described on this page as one defined clinical route. Its role, limits and possible alternatives are considered together rather than treating the method name as a personal recommendation.
02Who may be assessed for Medical Skin Care for Acne?+
Suitability depends on the medical question, history, examination, the exact product or device where relevant, realistic aims and an individual benefit–risk assessment.
03What remains undecided after an online review?+
Diagnosis, definitive suitability, the treatment protocol, product, dose or device settings, expected response and the option not to proceed remain subject to personal medical assessment.
04How are treatment and follow-up in Istanbul planned?+
The in-person examination remains the decision point. Expected early reactions, warning signs, the direct contact route, return travel and access to appropriate local medical care are discussed before treatment.
Next Step
Define the question · verify the option · compare alternatives